In the context of infectious diseases, IL-17 initiates innate repair responses and host defense against bacterial infections at the mucosa, but, intriguingly, upregulated production of IL-17 can also exacerbate the severity of some inflammation (32). Here, IL17A is linked to bacterial infectious disease.